KUKJEON PHARMACEUTICAL Co., Ltd

KOSDAQ:A307750 Stock Report

Market Cap: ₩269.4b

KUKJEON PHARMACEUTICAL Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jongho Hong

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership44.4%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

KUKJEON PHARMACEUTICAL's (KOSDAQ:307750) Problems Go Beyond Poor Profit

Mar 27
KUKJEON PHARMACEUTICAL's (KOSDAQ:307750) Problems Go Beyond Poor Profit

CEO

Jongho Hong (52 yo)

no data

Tenure

Mr. Jongho Hong serves as CEO at Kukjeon Pharmaceutical Co., Ltd.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.